We found that inhibiting AKT with MK-2206 attenuated Sema3C-mediated stemness and reduced Gli1 and c-Myc expression, providing new evidence that Sema3C functions via the AKT/Gli1/c-Myc axis in HCC cells. The gene discussed is AKT1; the disease is hepatocellular carcinoma.